Welcome to the 2021 IGCS Meeting Program Scheduling

The meeting will officially run on Central European Time (Rome time-zone, GMT+2)

To convert the meeting times to your local time Click Here

 

 

 

Displaying One Session

Hall 3

Session Type
Oral Posters
Room
Hall 3
Date
09/02/2021

OPTIMIZING THE NUMBER OF CYCLES OF NEOADJUVANT CHEMOTHERAPY IN ADVANCED EPITHELIAL OVARIAN CARCINOMA: A PROPENSITY-SCORE MATCHING ANALYSIS (ID 820)

Lecture Time
12:03 PM - 12:08 PM
Abstract

CORRELATION OF HRD STATUS WITH CLINICAL AND SURVIVAL OUTCOMES IN PATIENTS WITH ADVANCED-STAGE OVARIAN CANCER UNDERGOING FRONTLINE AND MAINTENANCE THERAPY. (ID 821)

Lecture Time
12:08 PM - 12:13 PM
Abstract

PROGRESSION FREE SURVIVAL AND OVERALL SURVIVAL AFTER BRCA1/2-ASSOCIATED EPITHELIAL OVARIAN CANCER: A MATCHED COHORT STUDY. (ID 815)

ELECTRONIC PATIENT-REPORTED OUTCOME (EPRO) MEASURES IN GYNECOLOGIC ONCOLOGY: INITIAL EXPERIENCE AFTER WORKFLOW IMPLEMENTATION (ID 825)

Lecture Time
12:18 PM - 12:23 PM
Abstract

PHASE I STUDY OF MIRVETUXIMAB SORAVTANSINE (MIRV) AND RUCAPARIB FOR RECURRENT ENDOMETRIAL, OVARIAN, FALLOPIAN TUBE OR PRIMARY PERITONEAL CANCER (ID 804)

Lecture Time
12:23 PM - 12:28 PM
Abstract

COST-EFFECTIVENESS OF DOSTARLIMAB IN ADVANCED RECURRENT DEFICIENT MISMATCH REPAIR ENDOMETRIAL CANCER PATIENTS (ID 810)

Lecture Time
12:28 PM - 12:33 PM
Abstract

POSTMENOPAUSAL STATUS AND ELEVATED SERUM LEVEL OF CANCER ANTIGEN 125 SIGNIFICANTLY PREDICTED CONCURRENT ENDOMETRIAL CANCER IN WOMEN DIAGNOSED WITH ATYPICAL ENDOMETRIAL HYPERPLASIA BEFORE SURGERY (ID 808)

Lecture Time
12:33 PM - 12:38 PM
Presenter
Abstract